MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.drugalcdep.2017.03.016

Медицинская библиотека · Drug and alcohol dependence · 2017

Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.

Haass-Koffler Carolina L, Goodyear Kimberly, Zywiak William H, Magill Molly, Eltinge Sarah E, Wallace Paul M, Long Victoria M, Jayaram-Lindström Nitya, Swift Robert M, Kenna George A, Leggio Lorenzo

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Preclinical and clinical research suggest that the α1 receptor antagonist prazosin reduces alcohol consumption. Furthermore, clinical studies indicate a role for prazosin in treating Post-Traumatic Stress Disorder (PTSD) symptoms and a recent trial suggested that pre-treatment blood pressure (BP) predicts therapeutic response for prazosin in PTSD patients. Whether pre-treatment BP may predict response to α1 blockers in alcohol-dependent (AD) patients is unknown. We previously reported a randomized controlled trial (RCT) where doxazosin, an α1 receptor antagonist with a more favorable pharmacokinetic profile than prazosin, reduced drinks per week (DPW) and heavy drinking days (HDD) in AD patients with a high family history density of alcoholism. In this study, we tested pre-treatment BP as another potentially valuable clinical moderator of doxazosin's response on alcohol consumption.

METHODS

This was a double-blind placebo-controlled RCT testing doxazosin up to 16mg/day in AD treatment-seeking patients (N=41). The hypothesized moderator effect of baseline standing systolic and diastolic BP on DPW and HDD was tested.

RESULTS

With pre-treatment standing diastolic BP as a moderator, there were significant BP x medication interactions for both DPW [**p=0.009, d=0.80] and HDD [*p=0.018, d=1.11]. Post-hoc analyses indicated significant doxazosin effects in patients with higher standing BP in reducing both DPW and HDD.

CONCLUSION

These findings suggest that higher standing diastolic BP at baseline (pre-treatment) may represent a predictor of doxazosin's response on alcohol consumption in AD patients. These results further elucidate the possible efficacy and mechanisms of action of α1 receptor antagonism in AD individuals.

Для цитирования: Haass-Koffler Carolina L, Goodyear Kimberly, Zywiak William H, Magill Molly, Eltinge Sarah E, Wallace Paul M, Long Victoria M, Jayaram-Lindström Nitya, Swift Robert M, Kenna George A, Leggio Lorenzo. Higher pretreatment blood pressure is associated with greater alcohol drinking reduction in alcohol-dependent individuals treated with doxazosin.. Drug and alcohol dependence. 2017. DOI: 10.1016/j.drugalcdep.2017.03.016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.